These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19401100)

  • 1. [Vancomycin or linezolid as the treatment of choice for grampositive nosocomial pneumonia].
    Márquez-Peiró JF; Climente-Martí M; Jiménez-Torres NV
    Farm Hosp; 2009; 33(1):55-6. PubMed ID: 19401100
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin.
    Kollef MH; Rello J; Cammarata SK; Croos-Dabrera RV; Wunderink RG
    Intensive Care Med; 2004 Mar; 30(3):388-94. PubMed ID: 14714107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid better than vancomycin in treating drug-resistant pneumonia.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):1, 6-7. PubMed ID: 15101393
    [No Abstract]   [Full Text] [Related]  

  • 4. Unresolved questions with the use of linezolid vs vancomycin for nosocomial pneumonia.
    Kalil AC; Puumala SE; Stoner J
    Chest; 2004 Jun; 125(6):2370-1. PubMed ID: 15189972
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia.
    Wunderink RG; Cammarata SK; Oliphant TH; Kollef MH;
    Clin Ther; 2003 Mar; 25(3):980-92. PubMed ID: 12852712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses.
    Powers JH; Ross DB; Lin D; Soreth J
    Chest; 2004 Jul; 126(1):314-5; author reply 315-6. PubMed ID: 15249482
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
    Plouffe JF
    Clin Infect Dis; 2000 Sep; 31 Suppl 4():S144-9. PubMed ID: 11017864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Bodmann KF
    Pharm Unserer Zeit; 2004; 33(1):38-41. PubMed ID: 14968711
    [No Abstract]   [Full Text] [Related]  

  • 9. Linezolid in VAP by MRSA: a better choice?
    Ioanas M; Lode H
    Intensive Care Med; 2004 Mar; 30(3):343-6. PubMed ID: 14767588
    [No Abstract]   [Full Text] [Related]  

  • 10. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxazolidinones and glycopeptides].
    Pigrau C
    Enferm Infecc Microbiol Clin; 2003 Mar; 21(3):157-64; quiz 165, 169. PubMed ID: 12586023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Wunderink RG; Rello J; Cammarata SK; Croos-Dabrera RV; Kollef MH
    Chest; 2003 Nov; 124(5):1789-97. PubMed ID: 14605050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid: implications for neurosurgical infections.
    Nguyen CM; Larive LL; Rhoney DH
    Neurol Res; 2003 Jan; 25(1):22-6. PubMed ID: 12564121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial pneumonia: therapy is just not good enough.
    Bauer TT
    Chest; 2003 Nov; 124(5):1632-4. PubMed ID: 14605025
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.
    Pletz MW; Burkhardt O; Welte T
    Eur J Med Res; 2010 Nov; 15(12):507-13. PubMed ID: 21163725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
    Kalil AC; Murthy MH; Hermsen ED; Neto FK; Sun J; Rupp ME
    Crit Care Med; 2010 Sep; 38(9):1802-8. PubMed ID: 20639754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of linezolid and vancomycin in nosocomial pneumonia: results of the multicenter double-blind study].
    Grudinina SA; Zubkov MM; Krotova LA; Kurdiukova IuP; Kutsenko MA; Marinin VF; Sidorenko SV; Sinpal'nikov AI; Solomatin AS; Sterkhova GV; Fesenko OV; Fomina IG; Chuchalin AG
    Antibiot Khimioter; 2002; 47(1):12-7. PubMed ID: 12077934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.